Prostate Cancer - Results from #24760

Low prostate-specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant prostate cancer at radical prostatectomy - Abstract September 18, 2012

Improved overall survival trends of men with newly diagnosed M1 prostate cancer: A SWOG phase III trial experience (S8494, S8894 and S9346) - Abstract September 18, 2012

Is a visible (hypoechoic) lesion at biopsy an independent predictor of prostate cancer outcome? - Abstract September 18, 2012

Solid state TL detectors for in vivo dosimetry in brachytherapy - Abstract September 18, 2012

Local staging of prostate cancer: Comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound - Abstract September 18, 2012

Diagnostic accuracy of ultra-high-b-value 3.0-T diffusion-weighted MR imaging for detection of prostate cancer - Abstract September 18, 2012

5 Alpha-reductase inhibitors and prostate cancer: A statement of the Committee of Cancerology of the French Association of Urology - Abstract September 18, 2012

Biomarker-based targeting of the androgen-androgen receptor axis in advanced prostate cancer - Abstract September 18, 2012

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: Final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study - Abstract September 18, 2012

Large urology group practice management: Reflections during Prostate Cancer Awareness Month September 17, 2012

The distribution of PSA age-specific profiles in healthy Irish men between 20 and 70 - Abstract September 17, 2012

Penile metastases of recurrent prostatic adenocarcinoma without PSA level increase: A case report - Abstract September 17, 2012

Reproducibility and clinical correlations of post-treatment changes on CT of prostate cancer bone metastases treated with chemotherapy - Abstract September 17, 2012

High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: Treatment evolution and mature results - Abstract September 17, 2012

Intermittent androgen suppression for rising PSA level after radiotherapy - Abstract September 17, 2012

Radiobiological model-based bio-anatomical quality assurance in intensity-modulated radiation therapy for prostate cancer - Abstract September 17, 2012

Appropriateness of the treatment of fatigued patients with stage IV cancer - Abstract September 17, 2012

A prospective study of total and ionized serum calcium and time to fatal prostate cancer - Abstract September 17, 2012

MicroRNA regulation of oncolytic adenovirus 6 for selective treatment of castration-resistant prostate cancer - Abstract September 17, 2012

Prostate cancer vaccines in clinical trials - Abstract September 17, 2012

Page 1239 of 1434